Julian Baker’s Cellectis CLLS Stock Holding History

Julian Baker’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-50,000	Closed	-$1.42M	–	102
2018 Q2	$1.42M	Hold	50,000	–	–	0.01%	99
2018 Q1	$1.58M	Hold	50,000	–	–	0.01%	94
2017 Q4	$1.46M	Hold	50,000	–	–	0.01%	102
2017 Q3	$1.42M	Hold	50,000	–	–	0.01%	103
2017 Q2	$1.29M	Hold	50,000	–	–	0.01%	98
2017 Q1	$1.2M	Hold	50,000	–	–	0.01%	98
2016 Q4	$848K	Hold	50,000	–	–	0.01%	111
2016 Q3	$1.2M	Hold	50,000	–	–	0.01%	105
2016 Q2	$1.33M	Hold	50,000	–	–	0.01%	111
2016 Q1	$1.38M	Hold	50,000	–	–	0.01%	110
2015 Q4	$1.55M	Hold	50,000	–	–	0.01%	112
2015 Q3	$1.32M	Hold	50,000	–	–	0.01%	113
2015 Q2	$1.8M	Hold	50,000	–	–	0.02%	106
2015 Q1	$1.73M	Buy	+50,000	New	+$1.81M	0.01%	110

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Julian Baker's CLLS Position: Q3 2018 in Review

Julian Baker sold out of Cellectis (CLLS) in Q3 2018, closing a stake of 50,000 shares — an estimated $1.42M sold.

Julian Baker first reported a position in CLLS in Q1 2015 and held it in 14 quarters. The position peaked at $1.8M in Q2 2015. 81 funds tracked by Wall St. Rank hold CLLS as of Q3 2018.

Julian Baker reported no remaining Cellectis position as of Q3 2018 after selling out during the quarter.
Julian Baker sold 50,000 Cellectis shares in Q3 2018, an estimated $1.42M.
Julian Baker first reported a position in Cellectis in Q1 2015 and held it in 14 quarters.
Julian Baker's Cellectis position peaked at $1.8M in Q2 2015.
81 funds tracked by Wall St. Rank held Cellectis as of Q3 2018.

Based on Baker Bros. Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.